Showing results (271-280 of 380) with videos related to

Sort By:
Pageof 38
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1995
Characterization of furoxans as a new class of tolerance-resistant nitrovasodilatorsM Hecker, W Vorhoff, A T Bara, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adductM Hecker, M Boese, V B Schini-Kerth, et al.
The Journal of Biological Chemistry|December 8, 1995
S-nitrosation of serum albumin by dinitrosyl-iron complexM Boese, P I Mordvintcev, A F Vanin, et al.
European Journal of Pharmacology|December 29, 1998
Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertensionJ Bauersachs, A Bouloumié, D Fraccarollo, et al.
Der Internist|November 5, 2004
[When is expensive pharmacotherapy good value for the money?]A Riesberg, M Velasco-Garrido, S Weinbrenner, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 19, 2014
[Economic Evaluation of Integrated Care Systems - Scientific Standard Specifications, Challenges, Best Practice Model]A Pimperl, J Schreyögg, H Rothgang, et al.
International Journal of Obesity (2005)|August 26, 2015
Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient miceK Schmitz, N Mangels, A Häussler, et al.
Plastic and Reconstructive Surgery|September 28, 2017
Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism ProphylaxisChristopher J Pannucci, Madison M Hunt, Kory I Fleming, et al.
Pageof 38